CS logo
small CS logo
Nuvisan GmbH

Neu Ulm, Germany
Pharmaceutical company in Neu-Ulm, Bavaria
Wegenerstraße 13, 89231 Neu-Ulm

About Nuvisan GmbH


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
10
Merck KGaA, Darmstadt, Germany
7
Bayer
4
Aptarion Biotech AG
2
BioVersys SAS
2
Cinfa Biotech
2
Max Zeller Soehne AG
2
Bial - Portela C S.A.
1
Dr. August Wolff GmbH & Co. KG Arzneimittel
1
Galapagos NV
1
Idorsia Pharmaceuticals Ltd.
1
Total Rows: 15

Clinical Trials at Nuvisan GmbH


During the past decade, Nuvisan GmbH conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 1 clinical trials were completed, i.e. on average, 2.9% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 1 clinical trials were completed. i.e. 6.3% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years22224477333388550000000000001100Started TrialsCompleted Trails201520162017201820192020202120220246810
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Assessment of the Pharmacodynamic Effect on Plasma Folate and Red Blood Cell Folate and Comparison of the Folate Metabolites During the 24 Weeks of Treatment (Yasmin + Metafolin Versus Yasmin + Folic Acid) Followed by a 20 Week Elimination Phase of Folate
2006-12-01
2008-01-01
Completed
172
Multiple Ascending Dose Study of SPC4955 in Healthy Subjects
2011-05-01
2011-11-01
Completed
18
First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PRS-080
2014-11-01
2015-08-01
Completed
48
Pilot Pharmacokinetic Study of a Prolonged-release Formulation of St. John's Wort Extract Ze 117
2015-11-01
2015-11-01
Completed
10
Pharmacokinetic and Pharmacodynamics of B12019 and Neulasta® in Healthy Subjects
2015-11-01
Completed
172
Immunogenicity and Pharmacodynamic of B12019 and Neulasta® in Healthy Subjects
2016-09-01
2017-05-01
Completed
96
Investigation of Ascending Concentrations of Glycopyrronium Bromide (GPB) in a Topical Formulation in Subjects With Axillary Hyperhidrosis
2016-11-01
2017-07-01
Completed
30
Bioavailability and Bioequivalence Study of Two Different Sources of Opicapone
2017-06-20
2017-08-28
Completed
56

Rows per page:

1–37 of 37

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Nuvisan GmbH" #1 sponsor was "Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany" with 10 trials, followed by "Merck KGaA, Darmstadt, Germany" with 7 trials sponsored, "Bayer" with 4 trials sponsored, "Aptarion Biotech AG" with 2 trials sponsored and "BioVersys SAS" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 15 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Nuvisan GmbH" #1 collaborator was "FGK Clinical Research GmbH" with 2 trials as a collaborator, "Nuvisan GmbH" with 2 trials as a collaborator, "ADIR, a Servier Group company" with 1 trials as a collaborator, "Charles River Biopharmaceutical Services GmbH" with 1 trials as a collaborator and "EUROCALIN Consortium" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.
Created with Highcharts 11.1.0Top Leading SponsorsMerck Healthcare KGaA,Darmstadt, Germany,an affiliate of MerckKGaA, Darmstadt,Germany: 10Merck Healthcare KGaA,Darmstadt, Germany,an affiliate of MerckKGaA, Darmstadt,Germany: 10Merck KGaA,Darmstadt, Germany: 7Merck KGaA,Darmstadt, Germany: 7Bayer: 4Bayer: 4Aptarion Biotech AG: 2Aptarion Biotech AG: 2BioVersys SAS: 2BioVersys SAS: 2Cinfa Biotech: 2Cinfa Biotech: 2Max Zeller Soehne AG: 2Max Zeller Soehne AG: 2Bial - Portela C S.A.: 1Bial - Portela C S.A.: 1Dr. August Wolff GmbH& Co. KG Arzneimittel:1Dr. August Wolff GmbH& Co. KG Arzneimittel:1Galapagos NV: 1Galapagos NV: 1

Created with Highcharts 11.1.0Top CollaboratorsFGK Clinical Research GmbH: 2FGK Clinical Research GmbH: 2Nuvisan GmbH: 2Nuvisan GmbH: 2ADIR, a Servier Groupcompany: 1ADIR, a Servier Groupcompany: 1Charles RiverBiopharmaceuticalServices GmbH: 1Charles RiverBiopharmaceuticalServices GmbH: 1EUROCALIN Consortium: 1EUROCALIN Consortium: 1Nuvisan Pharma Services: 1Nuvisan Pharma Services: 1

Clinical Trials Conditions at Nuvisan GmbH


According to Clinical.Site data, the most researched conditions in "Nuvisan GmbH" are "Healthy" (22 trials), "Healthy Volunteers" (3 trials), "Contraception" (2 trials), "Clinical Pharmacology" (1 trials) and "Diabetic Retinopathy" (1 trials). Many other conditions were trialed in "Nuvisan GmbH" in a lesser frequency.

Clinical Trials Intervention Types at Nuvisan GmbH


Most popular intervention types in "Nuvisan GmbH" are "Drug" (35 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (7 trials), "Evobrutinib" (4 trials), "Midazolam" (4 trials), "Tepotinib" (3 trials) and "BV100" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Nuvisan GmbH


The vast majority of trials in "Nuvisan GmbH" are 23 trials for "All" genders, 11 trials for "Male" genders and 3 trials for "Female" genders.

Clinical Trials Status at Nuvisan GmbH


Currently, there are NaN active trials in "Nuvisan GmbH". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 34 completed trials in Nuvisan GmbH, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Nuvisan GmbH, 35 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 1: 35Phase 1: 35Phase 2: 2Phase 2: 2

Created with Highcharts 11.1.0Trials StatusCompleted: 34Completed: 34Active, not recruiting: 1Active, not recruiting: 1Recruiting: 1Recruiting: 1Unknown status: 1Unknown status: 1